Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Rando

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Antimicrobial Agents and Chemotherapy|November 1, 1995
Inhibition of episomal hepatitis B virus DNA in vitro by 2,4-diamino-7- (2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-pyrrolo[2,3-d]pyrimidineJ O Ojwang, B K Bhattacharya, H B Marshall, et al.
European Journal of Pediatrics|July 1, 1990
Transient electrocardiographic changes suggesting myocardial ischaemia in newborn infants following tocolysis with beta-sympathomimeticsM Gemelli, F De Luca, R Manganaro, et al.
The Journal of Biological Chemistry|January 27, 1995
Suppression of human immunodeficiency virus type 1 activity in vitro by oligonucleotides which form intramolecular tetradsR F Rando, J Ojwang, A Elbaggari, et al.
Vaccine|April 1, 1996
The N-terminal 303 amino acids of the human cytomegalovirus envelope glycoprotein B (UL55) and the exon 4 region of the major immediate early protein 1 (UL123) induce a cytotoxic T-cell responseK Berencsi, E Gönczöl, V Endresz, et al.
The Journal of Reproductive Medicine|December 1, 1990
Studies on the transmission of viral disease via the CO2 laser plume and ejectaP M Wisniewski, M J Warhol, R F Rando, et al.
The Journal of Infectious Diseases|November 1, 1990
An adenovirus recombinant that expresses the human cytomegalovirus major envelope glycoprotein and induces neutralizing antibodiesG S Marshall, R P Ricciardi, R F Rando, et al.
Antimicrobial Agents and Chemotherapy|January 25, 2003
Toward the development of a virus-cell-based assay for the discovery of novel compounds against human immunodeficiency virus type 1Martin E Adelson, Annmarie L Pacchia, Malvika Kaul, et al.
Journal of Human Virology|January 11, 2000
The hepatitis C virus NS5B RNA-dependent RNA polymerase activity and susceptibility to inhibitors is modulated by metal cationsM H Alaoui-Lsmaili, M Hamel, L L'Heureux, et al.
Antisense & Nucleic Acid Drug Development|November 15, 1997
Sequence-specific inhibition of the tumor necrosis factor-alpha receptor I gene by oligodeoxynucleotides containing N7 modified 2'-deoxyguanosineJ O Ojwang, A F Lewis, G R Revankar, et al.
Antimicrobial Agents and Chemotherapy|October 3, 1999
Mechanism of action and in vitro activity of 1',3'-dioxolanylpurine nucleoside analogues against sensitive and drug-resistant human immunodeficiency virus type 1 variantsZ Gu, M A Wainberg, N Nguyen-Ba, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Antimicrobial Agents and Chemotherapy|November 1, 1995
Inhibition of episomal hepatitis B virus DNA in vitro by 2,4-diamino-7- (2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-pyrrolo[2,3-d]pyrimidineJ O Ojwang, B K Bhattacharya, H B Marshall, et al.
European Journal of Pediatrics|July 1, 1990
Transient electrocardiographic changes suggesting myocardial ischaemia in newborn infants following tocolysis with beta-sympathomimeticsM Gemelli, F De Luca, R Manganaro, et al.
The Journal of Biological Chemistry|January 27, 1995
Suppression of human immunodeficiency virus type 1 activity in vitro by oligonucleotides which form intramolecular tetradsR F Rando, J Ojwang, A Elbaggari, et al.
Vaccine|April 1, 1996
The N-terminal 303 amino acids of the human cytomegalovirus envelope glycoprotein B (UL55) and the exon 4 region of the major immediate early protein 1 (UL123) induce a cytotoxic T-cell responseK Berencsi, E Gönczöl, V Endresz, et al.
The Journal of Reproductive Medicine|December 1, 1990
Studies on the transmission of viral disease via the CO2 laser plume and ejectaP M Wisniewski, M J Warhol, R F Rando, et al.
The Journal of Infectious Diseases|November 1, 1990
An adenovirus recombinant that expresses the human cytomegalovirus major envelope glycoprotein and induces neutralizing antibodiesG S Marshall, R P Ricciardi, R F Rando, et al.
Antimicrobial Agents and Chemotherapy|January 25, 2003
Toward the development of a virus-cell-based assay for the discovery of novel compounds against human immunodeficiency virus type 1Martin E Adelson, Annmarie L Pacchia, Malvika Kaul, et al.
Journal of Human Virology|January 11, 2000
The hepatitis C virus NS5B RNA-dependent RNA polymerase activity and susceptibility to inhibitors is modulated by metal cationsM H Alaoui-Lsmaili, M Hamel, L L'Heureux, et al.
Antisense & Nucleic Acid Drug Development|November 15, 1997
Sequence-specific inhibition of the tumor necrosis factor-alpha receptor I gene by oligodeoxynucleotides containing N7 modified 2'-deoxyguanosineJ O Ojwang, A F Lewis, G R Revankar, et al.
Antimicrobial Agents and Chemotherapy|October 3, 1999
Mechanism of action and in vitro activity of 1',3'-dioxolanylpurine nucleoside analogues against sensitive and drug-resistant human immunodeficiency virus type 1 variantsZ Gu, M A Wainberg, N Nguyen-Ba, et al.
Pageof 7